Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1993 1
2014 1
2015 1
2016 3
2017 3
2018 2
2019 2
2020 4
2021 1
2022 1
2023 4
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, Piskin D, Ravelli A, Sinha R, Aletaha D, Allen C, Bassiri H, Behrens EM, Carcillo J, Carl L, Chatham W, Cohen JI, Cron RQ, Drewniak E, Grom AA, Henderson LA, Horne A, Jordan MB, Nichols KE, Schulert G, Vastert S, Demirkaya E, Goldbach-Mansky R, de Benedetti F, Marsh RA, Canna SW; HLH/MAS task force. Shakoory B, et al. Ann Rheum Dis. 2023 Oct;82(10):1271-1285. doi: 10.1136/ard-2023-224123. Epub 2023 Jul 24. Ann Rheum Dis. 2023. PMID: 37487610 Free PMC article.
Serum cytokine panels in pediatric clinical practice.
Gallo PM, Kim J, McNerney KO, Diorio C, Foley C, Kagami L, Wagner K, Petrosa WL, Conlon H, Gollomp KL, Canna SW, Seif AE, Conrad MA, Kelsen JR, Romberg N, Bassiri H, Sullivan KE, Teachey DT, Paessler ME, Behrens EM, Lambert MP. Gallo PM, et al. J Allergy Clin Immunol. 2025 Feb;155(2):594-604.e5. doi: 10.1016/j.jaci.2024.08.030. Epub 2024 Sep 18. J Allergy Clin Immunol. 2025. PMID: 39303891 Free PMC article.
Diurnal variation of the human urinary TRH excretion measured by radioimmunoassay.
Utsumi M, Tateiwa M, Makimura H, Yamada A, Mori H, Kusaka T, Sakoda M, Baba S. Utsumi M, et al. Endocrinol Jpn. 1975 Dec;22(6):509-16. doi: 10.1507/endocrj1954.22.509. Endocrinol Jpn. 1975. PMID: 821746 Free article.
Urine TRH was estimated by the radioimmunoassay which was accomplished according to the method of Bassiri and Utiger. Minimum detectable dose of TRH was 25 pg and recovery of TRH ranged from 72% to 112% in our laboratory. ...Total urinary TRH excretion of 24 hours was 817- …
Urine TRH was estimated by the radioimmunoassay which was accomplished according to the method of Bassiri and Utiger. Minimum detecta …
GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.
Abac AG, Abouelfettouh I, Acernese F, Ackley K, Adamcewicz C, Adhicary S, Adhikari D, Adhikari N, Adhikari RX, Adkins VK, Afroz S, Agapito A, Agarwal D, Agathos M, Aggarwal N, Aggarwal S, Aguiar OD, Ahrend IL, Aiello L, Ain A, Ajith P, Akutsu T, Al-Kershi S, Al-Shammari S, Albanesi S, Ali W, Alléné C, Allocca A, Altin PA, Alvarez-Lopez S, Amar W, Amarasinghe O, Amato A, Amicucci F, Amra C, Ananyeva A, Anderson SB, Anderson WG, Andia M, Ando M, Andrés-Carcasona M, Andrić T, Anglin J, Ansoldi S, Antelis JM, Antier S, Aoumi M, Appavuravther EZ, Appert S, Apple SK, Arai K, Araya A, Araya MC, Arca Sedda M, Areeda JS, Aritomi N, Armato F, Armstrong S, Arnaud N, Arogeti M, Aronson SM, Ashton G, Aso Y, Asprea L, Assiduo M, Assis de Souza Melo S, Aston SM, Astone P, Attadio F, Aubin F, AultONeal K, Avallone G, Avila EA, Babak S, Badger C, Bae S, Bagnasco S, Baiotti L, Bajpai R, Baka T, Baker AM, Baker KA, Baker T, Baldi G, Baldicchi N, Ball M, Ballardin G, Ballmer SW, Banagiri S, Banerjee B, Bankar D, Baptiste TM, Baral P, Baratti M, Barayoga JC, Barish BC, Barker D, Barman N, Barneo P, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartoletti AM, Barton MA, Bartos I, Basalaev A, Bass… See abstract for full author list ➔ Abac AG, et al. Phys Rev Lett. 2025 Sep 12;135(11):111403. doi: 10.1103/kw5g-d732. Phys Rev Lett. 2025. PMID: 41004747 Free article.
The signal was emitted by the coalescence of two black holes with near-equal masses m_{1}=33.6_{-0.8}^{+1.2}M_{ } and m_{2}=32.2_{-1.3}^{+0.8}M_{ }, and small spins chi_{1,2} 0.26 (90% credibility) and negligible eccentricity e 0.03. Postmerger data ex …
The signal was emitted by the coalescence of two black holes with near-equal masses m_{1}=33.6_{-0.8}^{+1.2}M_{ } and m …
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.
Schuelke MR, Bassiri H, Behrens EM, Canna S, Croy C, DiNofia A, Gollomp K, Grupp S, Lambert M, Lambrix A, Maude SL, Myers R, Newman H, Petrosa W, Seif A, Sullivan KE, Teachey DT, Diorio C. Schuelke MR, et al. Blood Adv. 2023 Sep 26;7(18):5603-5607. doi: 10.1182/bloodadvances.2023010712. Blood Adv. 2023. PMID: 37721859 Free PMC article. No abstract available.
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri H, Benavides A, Haber M, Gilmour SK, Norris MD, Hogarty MD. Bassiri H, et al. Transl Pediatr. 2015 Jul;4(3):226-38. doi: 10.3978/j.issn.2224-4336.2015.04.06. Transl Pediatr. 2015. PMID: 26835380 Free PMC article. Review.
Current trial designs include testing lower dose DFMO alone (2,000 mg/m(2)/day) starting at the completion of standard therapy, or higher doses combined with chemotherapy (up to 9,000 mg/m(2)/day) for patients with relapsed disease that has progressed. ...
Current trial designs include testing lower dose DFMO alone (2,000 mg/m(2)/day) starting at the completion of standard therapy, or hi …
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Diorio C, Anderson EM, McNerney KO, Goodwin EC, Chase JC, Bolton MJ, Arevalo CP, Weirick ME, Gouma S, Vella LA, Henrickson SE, Chiotos K, Fitzgerald JC, Kilbaugh TJ, John ARO, Blatz AM, Lambert MP, Sullivan KE, Tartaglione MR, Zambrano D, Martin M, Lee JH, Young P, Friedman D, Sesok-Pizzini DA, Hensley SE, Behrens EM, Bassiri H, Teachey DT. Diorio C, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28693. doi: 10.1002/pbc.28693. Epub 2020 Sep 4. Pediatr Blood Cancer. 2020. PMID: 32885904 Free PMC article.
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children.
Diorio C, Shaw PA, Pequignot E, Orlenko A, Chen F, Aplenc R, Barrett DM, Bassiri H, Behrens E, DiNofia AM, Gonzalez V, Koterba N, Levine BL, Maude SL, Meyer NJ, Moore JH, Paessler M, Porter DL, Bush JL, Siegel DL, Davis MM, Zhang D, June CH, Grupp SA, Melenhorst JJ, Lacey SF, Weiss SL, Teachey DT. Diorio C, et al. Blood Adv. 2020 Oct 27;4(20):5174-5183. doi: 10.1182/bloodadvances.2020002592. Blood Adv. 2020. PMID: 33095872 Free PMC article.
28 results